Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Angelika Eibl"'
Autor:
Peter Borchmann, Horst Mueller, Andreas Engert, Joerg H. Renno, Karolin Behringer, Teresa Halbsguth, Angelika Eibl, Helen Goergen, Johannes Rosenbrock, Michael Fuchs, Marietta Kuehr, M. von Wolff, Dennis A. Eichenauer, Volker Diehl, K. van der Ven, Indra Thielen, Katrin S. Reiners
Publikováno v:
Annals of Oncology. 31:1093
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29ba307008f373e3ea2e99c631f6ab8c
https://doi.org/10.1016/j.annonc.2020.05.020
https://doi.org/10.1016/j.annonc.2020.05.020
Autor:
Jorg H. Renno, Andreas Engert, Volker Diehl, Peter Borchmann, Michael Fuchs, Indra Thielen, Katrin van der Ven, Thomas Schober, Katrin S. Reiners, Martin Wiehlpütz, Michael von Wolff, Johannes Rosenbrock, Teresa Halbsguth, Karolin Behringer, Carsten Wessels, Helen Goergen, Horst Mueller, Angelika Eibl, Volker Stumpf, Marietta Kuehr
Publikováno v:
Behringer, Karolin; Mueller, Horst; Goergen, Helen; Thielen, Indra; Eibl, Angelika Diana; Stumpf, Volker; Wessels, Carsten; Wiehlpütz, Martin; Rosenbrock, Johannes; Halbsguth, Teresa; Reiners, Katrin S; Schober, Thomas; Renno, Jorg H; von Wolff, Michael; van der Ven, Katrin; Kuehr, Marietta; Fuchs, Michael; Diehl, Volker; Engert, Andreas and Borchmann, Peter (2013). Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. Journal of clinical oncology, 31(2), pp. 231-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2012.44.3721
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy is needed. Therefore, we analyzed gonadal functions in survivors of HL. Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1bc6e45c6a3c2f5cf4633407484a4f
https://pubmed.ncbi.nlm.nih.gov/23150709
https://pubmed.ncbi.nlm.nih.gov/23150709
Autor:
Volker Diehl, Teresa Halbsguth, Johannes Rosenbrock, Angelika Eibl, Helen Goergen, K. van der Ven, Indra Thielen, Michael Fuchs, Peter Borchmann, Horst Mueller, Andreas Engert, Dennis A. Eichenauer, Joerg H. Renno, Karolin Behringer, Katrin S. Reiners, Marietta Kuehr, M. von Wolff
Publikováno v:
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575
Background In the HD14 trial, 2× BEACOPPescalated+2× ABVD (2+2) has improved the primary outcome. Compared with 4× ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54176209b9f14dd78f4a86188341d1b3
https://pubmed.ncbi.nlm.nih.gov/32553542
https://pubmed.ncbi.nlm.nih.gov/32553542
Autor:
Martin Wiehlpuetz, Michael von Wolff, Volker Stumpf, Marietta Kuehr, Peter Borchmann, Michael Fuchs, Teresa Halbsguth, Thomas Schober, Horst Mueller, Angelika Eibl, Katrin S. Reiners, Johannes Rosenbrock, Volker Diehl, Joerg H. Renno, Karolin Behringer, Carsten Wessels, Helen Goergen, Katrin van der Ven, Andreas Engert, Indra Thielen
Publikováno v:
Blood. 120:2636-2636
Abstract 2636 Purpose: To improve fertility advice in HL patients before treatment and counseling during survivorship, detailed information on the impact of chemotherapy is needed. Therefore, we analyzed gonadal function in survivors after treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1be8e5892b3f3d7c2bd70b82071cd664
https://doi.org/10.1182/blood.v120.21.2636.2636
https://doi.org/10.1182/blood.v120.21.2636.2636
Autor:
Angelika Eibl, Andreas Engert, Peter Borchmann, Teresa Halbsguth, Katrin S. Reiners, Helen Goergen, Horst Mueller, Karolin Behringer, Johannes Rosenbrock, Indra Thielen, Volker Diehl
Publikováno v:
Blood. 118:432-432
Abstract 432 Purpose: Two cycles of BEACOPPescalated followed by two cycles of ABVD (“2+2”) improves the primary outcome in early unfavorable HL patients as shown in the GHSG HD14 trial. Compared to 4xABVD, this benefit might be compromised by mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e10613e9f769d0fbd441d8336c6277c
https://doi.org/10.1182/blood.v118.21.432.432
https://doi.org/10.1182/blood.v118.21.432.432